Breaks Categories: Stock Spotlights

FridayFeb 24, 2017 11:10 am

NetworkNewsBreaks – Auris Medical’s (NASDAQ: EARS) AM-111 Receives FDA Fast Track Designation to Treat Acute Sensorineural Hearing Loss

Auris Medical (NASDAQ: EARS) shares rose 13% this morning on news of the reception of Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss (ASNHL) from the U.S. Food and Drug Administration (FDA). The company is currently evaluating AM-111 in two phase 3 clinical trials. The first is the HEALOS trial, which is being conducted in several European and Asian countries. Auris Medical expects to complete enrollment in the second quarter of 2017 and report top-line results from this trial in the third quarter of 2017. The second trial, ASSENT, is being conducted in the U.S.,…

Continue Reading

ThursdayFeb 23, 2017 11:26 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Adds Over 100 New Agents and Brokers in Tough Climate

While market reports show low inventory of houses on the market, eXp World Holdings doesn’t seem to be affected by the overall concern for real estate businesses in the United States. In fact, the company continues to grow. “Although the end of 2016 showed cause for concern for real estate businesses across the country, inventory for January moved at a 4% faster annual rate (http://nnw.fm/obP83). This stronger than usual off-season has left a low volume of available homes for sale with very high prices. But this dip in volume has not halted the rising interest in eXp World Holdings, Inc.…

Continue Reading

ThursdayFeb 23, 2017 11:21 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) Forecasts Growth through Acquisitions, Joint Ventures in 2017

Singlepoint’s (OTC: SING) founder, president and CEO Greg Lambrecht recently gave an interview on Money TV with Donald Baillargeon, discussing the company’s acquisition strategy and recent stock performance. “The company’s massive success on the market in terms of stock price and volume has also drawn the interest of institutional investors. We’re getting a lot of attention from Wall Street and other that, even though we’re a Pink and right now we’re offering rule 144, that doesn’t seem to bother them. With our volume and stock price, we have a lot of interested parties that want to invest in Singlepoint and I…

Continue Reading

WednesdayFeb 22, 2017 10:44 am

NetworkNewsBreaks – Stealth Technologies, Inc. (STTH) Attends Leading Real Estate, Home Staging Conference as Part of Strategic Growth Initiative

Security and personal protection company Stealth Technologies, Inc. (OTCQB: STTH) this morning offered an update on its attendance at the International Association of Home Staging Professionals (IAHSP) and Real Estate Conference Expo in Fort Lauderdale, Florida. The company recently attended the conference as part of its ongoing efforts to expand its product footprint across various industries and distributors, providing an opportunity for Stealth Technologies to showcase its innovative products while networking with key industry professionals. “We believe the conference was a success as it introduced our innovative products to various potential distributors and formed strategic relationships with industry leaders,” Brian…

Continue Reading

TuesdayFeb 21, 2017 11:50 am

NetworkNewsBreaks – Rentech, Inc. (NASDAQ: RTK) Plummets 45% on Halted Production at Wawa Facility

Shares of Rentech (NASDAQ: RTK) are down 46% following the company’s announcement that its board has decided to idle the Wawa facility due to equipment and operational issues that would require additional unbudgeted capital investment, as well as continued uncertainty around profitability on pellets produced at the facility. The company said it expects to complete a safe and orderly idling of the facility in approximately two weeks. After the plant is idled, a small number of workers will maintain the plant so that it can resume operations with minimal resources if there is interest from a third party to invest…

Continue Reading

TuesdayFeb 21, 2017 11:48 am

NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Initiates Collaborative Research Program with Viatar for Early Pancreatic Cancer Detection

Interpace Diagnostics (NASDAQ: IDXG) is trading higher on news of its collaborative research program with Viatar CTC Solutions Inc. The partnership will combine Viatar's circulating tumor cell collection technology with Interpace's commercialized PancraGEN™ assay used to help assess unknown pancreatic cancer biopsies in patients with pancreatic cysts. Studies are being designed to identify patients most likely to develop pancreatic cancer in the near future as well as to detect pancreatic cancer at its earliest stage of development. These studies may lead to the enactment of early diagnostic testing and assessment for patients with pancreatic diseases, as well as for those…

Continue Reading

FridayFeb 17, 2017 1:09 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Spots Revenue-generating Opportunities in Shingles Recycling

National Waste Management (OTC: NWMH) continues to find new forms of revenue, and through market observation expects to see a significant increase in shingles recycling. “National Waste projects exponential growth in the coming years for the recycling of shingles. The company plans on adding a portable picking station at its landfill in order to increase its concrete recycling program by 25%. Overall, the portable picking station is expected to boost National Waste’s recyclables rate, the company said. National Waste also sells ground wood product to bio-mass energy plants. Additionally, the company markets a line of its own mulch and garden…

Continue Reading

FridayFeb 17, 2017 12:29 pm

NetworkNewsBreaks – MTBC (NASDAQ: MTBC) Partners with Pikeville Medical Center for East Kentucky Heart Ball

MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a provider of proprietary, cloud-based electronic health records, practice management and mHealth solutions, has partnered with Pikeville Medical Center as a key event sponsor for the hospital's East Kentucky Heart Ball. The fundraiser benefits Pikeville's Heart and Vascular Institute. MediGain Practice Management, an MTBC company, has provided end-to-end revenue cycle management services to Pikeville since October 2016. Every year, the fundraiser brings together a variety of guests including medical, business, and political leaders. Over 400 people attended the fundraiser to show their support this year. "The fulfillment of Pikeville's mission ensures that area residents can…

Continue Reading

FridayFeb 17, 2017 10:42 am

NetworkNewsBreaks – Social Reality, Inc. (NASDAQ: SRAX) Takes Aim at Growing Digital Ad Markets

As a progressive Internet advertising firm, Social Reality (NASDAQ: SRAX) has its sights on the worldwide real-time bidding (RTB) and social media advertising markets. “Designed to position itself in these multi-billion dollar markets, Social Reality, Inc. is a multi-platform company specializing in digital advertising. Its Social Reality Ad Exchange is a real-time buying and selling management platform designed for launching social media and other campaigns. SRAX Social offers targeted ad purchasing in the digital marketplace, while SRAX.md is designed to help clients reach health care professionals.” To view the full article, visit: http://nnw.fm/CkN0u About Social Reality Social Reality, Inc. is…

Continue Reading

FridayFeb 17, 2017 9:57 am

NetworkNewsBreaks – Heat Biologics, Inc. (NASDAQ: HTBX) Shares Climb following Presentation of Positive Immune Data on HS-410 Phase 2 Bladder Cancer Trial

Shares of Heat Biologics (NASDAQ: HTBX) are up 8% on news that the company presented immunological data from its phase 2 trial evaluating HS-410 either alone or in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) at the 2017 Genitourinary Cancers Symposium. Researchers reported that HS-410, in combination with BCG, is generally well-tolerated, and that HS-410 activates CD8+ T cells and that these immune responders appear to have a lower recurrence rate than non-immune responders. Overall, this data strengthens support for the vaccine mechanism of action and clinical proof-of-concept of immune activation. “These data continue to support…

Continue Reading